260 related articles for article (PubMed ID: 34336873)
1. Genetics of Severe Cutaneous Adverse Reactions.
Yang SC; Chen CB; Lin MY; Zhang ZY; Jia XY; Huang M; Zou YF; Chung WH
Front Med (Lausanne); 2021; 8():652091. PubMed ID: 34336873
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.
Chung WH; Hung SI
J Dermatol Sci; 2012 Jun; 66(3):190-6. PubMed ID: 22541332
[TBL] [Abstract][Full Text] [Related]
3. Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs.
Wung CH; Wang CW; Lai KC; Chen CB; Chen WT; Hung SI; Chung WH;
Front Pharmacol; 2023; 14():1183491. PubMed ID: 37180708
[TBL] [Abstract][Full Text] [Related]
4. Chemokines in Severe Cutaneous Adverse Reactions (SCARs).
Miyagawa F; Asada H
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34204146
[TBL] [Abstract][Full Text] [Related]
5. Stevens-Johnson syndrome and toxic epidermal necrolysis: risk factors, causality assessment and potential prevention strategies.
Lin CC; Chen CB; Wang CW; Hung SI; Chung WH
Expert Rev Clin Immunol; 2020 Apr; 16(4):373-387. PubMed ID: 32154748
[No Abstract] [Full Text] [Related]
6. Pharmacogenomic Advances in the Prediction and Prevention of Cutaneous Idiosyncratic Drug Reactions.
Pan RY; Dao RL; Hung SI; Chung WH
Clin Pharmacol Ther; 2017 Jul; 102(1):86-97. PubMed ID: 28295240
[TBL] [Abstract][Full Text] [Related]
7. Association between
Wattanachai P; Amornpinyo W; Konyoung P; Purimart D; Khunarkornsiri U; Pattanacheewapull O; Tassaneeyakul W; Nakkam N
Front Pharmacol; 2023; 14():1248386. PubMed ID: 37795024
[No Abstract] [Full Text] [Related]
8. Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes.
Sukasem C; Pratoomwun J; Satapornpong P; Klaewsongkram J; Rerkpattanapipat T; Rerknimitr P; Lertpichitkul P; Puangpetch A; Nakkam N; Konyoung P; Khunarkornsiri U; Disphanurat W; Srisuttiyakorn C; Pattanacheewapull O; Kanjanawart S; Kongpan T; Chumworathayi P; Saksit N; Bruminhent J; Tassaneeyakul W; Chantratita W; Pirmohamed M
Clin Pharmacol Ther; 2020 Nov; 108(5):1078-1089. PubMed ID: 32452529
[TBL] [Abstract][Full Text] [Related]
9. Genotyping
Jantararoungtong T; Tempark T; Koomdee N; Medhasi S; Sukasem C
Expert Opin Drug Metab Toxicol; 2021 Sep; 17(9):1049-1064. PubMed ID: 34148467
[No Abstract] [Full Text] [Related]
10. Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.
Mustafa SS; Ostrov D; Yerly D
Curr Allergy Asthma Rep; 2018 Mar; 18(4):26. PubMed ID: 29574562
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions.
Chang CJ; Chen CB; Hung SI; Ji C; Chung WH
Front Pharmacol; 2020; 11():969. PubMed ID: 32714190
[TBL] [Abstract][Full Text] [Related]
12. Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms.
Dao RL; Su SC; Chung WH
Asia Pac Allergy; 2015 Apr; 5(2):59-67. PubMed ID: 25938070
[TBL] [Abstract][Full Text] [Related]
13. Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population.
Chang CC; Ng CC; Too CL; Choon SE; Lee CK; Chung WH; Hussein SH; Lim KS; Murad S
Pharmacogenomics J; 2017 Mar; 17(2):170-173. PubMed ID: 26927288
[TBL] [Abstract][Full Text] [Related]
14. Severe Cutaneous Adverse Reactions to Anti-tuberculosis Drugs in Korean Patients.
Jin HJ; Kang DY; Nam YH; Ye YM; Koh YI; Hur GY; Kim SH; Yang MS; Kim S; Jeong YY; Kim MH; Choi JH; Kang HR; Jo EJ; Park HK;
Allergy Asthma Immunol Res; 2021 Mar; 13(2):245-255. PubMed ID: 33474859
[TBL] [Abstract][Full Text] [Related]
15. Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators.
Chu MT; Chang WC; Pao SC; Hung SI
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672685
[TBL] [Abstract][Full Text] [Related]
16. Phenotypes of Severe Cutaneous Adverse Reactions Caused by Nonsteroidal Anti-inflammatory Drugs.
Lee SY; Nam YH; Koh YI; Kim SH; Kim S; Kang HR; Kim MH; Lee JG; Park JW; Park HK; La HO; Kim MY; Park SJ; Kwon YE; Jung JW; Kim SH; Kim CW; Yang MS; Kang MG; Lee JY; Kim JH; Kim SH; Hur GY; Jee YK; Jin HJ; Park CS; Jeong YY; Ye YM
Allergy Asthma Immunol Res; 2019 Mar; 11(2):212-221. PubMed ID: 30661313
[TBL] [Abstract][Full Text] [Related]
17. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.
Chung WH; Hung SI
Allergol Int; 2010 Dec; 59(4):325-32. PubMed ID: 20962567
[TBL] [Abstract][Full Text] [Related]
18. HLA-B genotyping to detect carbamazepine-induced Stevens-Johnson syndrome: implications for personalizing medicine.
Hung SI; Chung WH; Chen YT
Per Med; 2005 Aug; 2(3):225-237. PubMed ID: 29793265
[TBL] [Abstract][Full Text] [Related]
19. A retrospective, 5-year, clinicoepidemiological study of severe cutaneous adverse reactions (SCARs).
Singh GK; Mitra B; Arora S; Akhoon N; Verma R; Sharma P; Mitra D
Int J Dermatol; 2021 May; 60(5):579-588. PubMed ID: 33454956
[TBL] [Abstract][Full Text] [Related]
20. Severe cutaneous adverse reaction associated with antiseizure medications: Diagnosis, management, and prevention.
Brandt C; McGuire L; Uetrecht J
Epilepsy Behav; 2021 Apr; 117():107844. PubMed ID: 33639435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
